AI-generated summary
This update reviews advances in photodynamic therapy combined with laser-assisted drug delivery, in which ablative fractional lasers are used to improve drug uptake into the skin. The authors report that this approach has been successfully used to treat non-melanoma skin cancer, including field cancerization, and that daylight and artificial daylight systems are now also used. The abstract is a narrative update rather than a systematic study.
- Who or what was studied
- Patients with non-melanoma skin cancer, including field cancerization; the abstract does not state a sample size.
- Limits stated in the abstract
- The abstract is a narrative update without stated sample sizes, quantitative outcomes, or a described review method.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Photodynamic therapy, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.